Article
Local ablative radiotherapy on oligo-progression while continued on epidermal growth factor receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer patients: A longer cohort.
Asia-Pacific journal of clinical oncology - 1 Dec 2022
Mok Florence Siu Ting, Tong Macy, Loong Herbert H, Mok Tony S K
Abstract excerpt
BACKGROUND: The effect of adding local ablative radiotherapy on oligo-progression while continuing EGFR-TKIs in advanced non-small cell Lung cancer (NSCLC) patients is to be determined. METHODS: Outcomes of patients with stage IV NSCLC harboring EGFR-activating mutations having ≤5 sites of oligo-progression while on EGFR-TKIs and given one to eight fractions of local ablative radiotherapy (LAR) were reviewed from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.